Bayer Schering Pharma AG News Archives

“The CHMP's recommendation represents an important milestone for Zevalin, as it recognizes the potential value that consolidation therapy with Zevalin can offer to patients with follicular lymphoma”

Main Category: Lymphoma / Leukemia Also Included In: Regulatory Affairs / Drug Approvals ; Clinical Trials / Drug Trials ; Pharma Industry / Biotech Industry Article Date: 24 Mar 2008 - 0:00 PDT newsletters ... via Medical News Today

“This therapy option will provide clinicians with a treatment regimen that truly could help many of their patients to an extended progression-free survival.”

Bayer Schering Pharma AG has received a positive opinion from the European Committee for Medicinal Products for Human Use recommending Zevalin as consolidation therapy after remission induction in previously ... via Med Ad News